Prot #R668-AD-1652: A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Dupilumab Administered Concomitantly with Topical Corticosteroids in Patients, ≥6 Years to <12 Years of Age, with Severe Atopic Dermatitis

Project: Research project

Project Details

StatusFinished
Effective start/end date3/16/183/16/21

Funding

  • ICON Clinical Research Limited (Prot #R668-AD-1652)
  • Regeneron Pharmaceuticals, Inc. (Prot #R668-AD-1652)